After management posted mixed results overnight, SandRidge Energy is trading lower today. We believe the stock is oversold.
Atmel, DepoMed and SandRidge Energy are set to report after the close.
Revenue and earnings come in below estimates, but its bookings remain strong.
It's a work in progress, but we have faith in management.
We're interested in hearing the state of the offshore drilling market.
We'll look for progress turning around the contract-order backlog.
We will buy shares of Unilife, which is oversold currently.
As the market ended the week with losses, we used the decline to add shares to three of our model portfolio positions.
We consider today's pullback to be a buying opportunity as this name posted solid core bookings in its earnings report this week.
We will maintain our Three rating on the stock.